Related Experiment Videos
Treatment of hemoglobin Bart's hydrops with bone marrow transplantation
1Department of Pediatrics, Prince of Wales Hospital, Chinese University of Hong Kong.
The Journal of Pediatrics
|June 17, 1998
Abstract:
A 21-month-old girl with hemoglobin Bart's hydrops received bone marrow transplantation (BMT) from a matched sibling. No major BMT-related complications developed. Hemoglobin levels remained greater than 10 gm/dl for 20 months without blood transfusion support despite the presence of residual host hemopoietic cells from 2 months after BMT. We suggest consideration of this therapeutic option for surviving patients.